Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_2
1
33%
Ph phase_4
1
33%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)

Trials by Status

unknown133%
withdrawn133%
not_yet_recruiting133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_2

The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label Trial

NCT07583862
unknownphase_3

Efficacy and Safety of Timolol for TKI Induced Paronychia

NCT06140186
withdrawnphase_4

Topical Timolol for the Treatment of Benign Vascular Periocular Lesions

NCT01250457

Clinical Trials (3)

Showing 3 of 3 trials
NCT07583862Phase 2

The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label Trial

Not Yet Recruiting
NCT06140186Phase 3

Efficacy and Safety of Timolol for TKI Induced Paronychia

Unknown
NCT01250457Phase 4

Topical Timolol for the Treatment of Benign Vascular Periocular Lesions

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3